PCK 21.2% 4.0¢ painchek ltd

PainChek General Discussion, page-8554

  1. 4,303 Posts.
    lightbulb Created with Sketch. 372
    In the small cap arena, most analyst reports ( and specifically the initial report) are just ‘guns for hire’. It isn’t abnormal to see them act differently to their reported position. At best they are just reporters of already published material. But always do your own sums. In the Nov report I believe their revenue numbers allow too much of a lag on gathering in the $5m plus there is no allowance for a significant ramp up in UK revenue. Besides for the next two years or so we are best watching the cash flow statement and the ARRU. It seems BE in FY 20 will need to cover fixed costs of around $7.5m - this company isn’t over extravagant with their spending. There is no need for thick shag pile carpets, marble and the statue of Venus de milo in reception...just get on and demonstrate the effectiveness of the product/ technology.
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.007(21.2%)
Mkt cap ! $65.43M
Open High Low Value Volume
3.5¢ 4.0¢ 3.5¢ $114.1K 2.979M

Buyers (Bids)

No. Vol. Price($)
2 503170 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 5683729 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.